Published in Vasc Health Risk Manag on April 18, 2016
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet (2002) 44.28
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol (2009) 9.40
Spontaneous intracerebral hemorrhage. N Engl J Med (2001) 8.60
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol (1998) 6.48
Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol (2009) 6.02
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol (2003) 5.77
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 5.57
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med (1989) 4.31
Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition. JAMA Neurol (2014) 3.90
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol (2005) 3.56
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology (2006) 3.16
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol (2009) 2.67
ICU-acquired weakness. Chest (2007) 2.61
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51
New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther (1999) 2.29
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis. Circulation (2011) 2.17
Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol (2011) 2.02
Statin safety: an overview and assessment of the data--2005. Am J Cardiol (2006) 1.91
Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol (2014) 1.73
Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol (2008) 1.63
Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology (2009) 1.49
Meta-analysis of Statin Use for the Acute Therapy of Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis (2015) 1.42
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke (2000) 1.40
Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke (2014) 1.32
Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2013) 1.31
Safety considerations for statins. Curr Opin Lipidol (2002) 1.29
Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther (2005) 1.25
Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke (2012) 1.22
Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab (2005) 1.18
Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke (1993) 1.17
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. J Pharmacol Exp Ther (2004) 1.16
Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke (2014) 1.15
Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke (2014) 1.08
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol (2010) 1.08
Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci (2010) 1.05
Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke (2012) 0.98
Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study. Stroke (2012) 0.93
Cardiovascular effects of statins, beyond lipid-lowering properties. Pharmacol Res (2014) 0.92
Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke (2013) 0.91
Apolipoprotein E, statins, and risk of intracerebral hemorrhage. Stroke (2013) 0.88
Association of statins and statin discontinuation with poor outcome and survival after intracerebral hemorrhage. Stroke (2012) 0.86
Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke. J Neurol (2008) 0.84
Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use. Eur J Neurol (2015) 0.83
Statins in Acute Ischemic Stroke: A Systematic Review. J Stroke (2015) 0.83
Molecular mechanisms underlying the effects of statins in the central nervous system. Int J Mol Sci (2014) 0.83
Statin therapy and the risk of intracerebral haemorrhage: a nationwide observational study. Int J Stroke (2015) 0.81
Use of statin during hospitalization improves the outcome after intracerebral hemorrhage. CNS Neurosci Ther (2014) 0.80
Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res (2015) 0.80
Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis. J Neurol Neurosurg Psychiatry (2015) 0.79
Clinicoradiological profile and serum lipid levels of intracerebral hemorrhage in prior statin users. Intern Med (2011) 0.79
Approach to neuromuscular disorders in the intensive care unit. Neurocrit Care (2005) 0.79
Neuromuscular disorders in critical illness. Clin Neurol Neurosurg (2006) 0.78
Lack of association between cerebral microbleeds and low serum cholesterol in patients with acute intracerebral hemorrhage. Clin Neurol Neurosurg (2010) 0.77
Long-term improvement in outcome after intracerebral hemorrhage in patients treated with statins. J Stroke Cerebrovasc Dis (2013) 0.77
Statin use in spontaneous intracerebral hemorrhage: a systematic review and meta-analysis. Int J Stroke (2015) 0.76
Clinical, radiological, and pathological aspects of cerebrovascular disease associated with drug abuse. Stroke (1993) 0.76
HMG-CoA reductase inhibitor protects against in vivo arterial thrombosis by augmenting platelet-derived nitric oxide release in rats. J Cardiovasc Pharmacol (2005) 0.76